drugset / Trial / NCT07018453
A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the glycemic control and safety of SHR-3167 and Insulin Degludec in type 2 diabetic participants treated with basal insulin with or without oral antidiabetic drugs.
Timeline
- Start
- 2025-07-16
- Primary completion
- 2026-02
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-3167 | Unknown | — | — |
| Comparator | insulin degludec | Protein / enzyme biologic | — | — |